+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Advancements across Skin Testing Sector

  • ID: 4244298
  • Report
  • April 2017
  • Region: Global
  • 15 pages
  • Frost & Sullivan
1 of 2
This Genetic Technology TOE depicts trends across the skin testing sector. Technology profiles for skin mimicking, tissue models, in vitro testing and tissue engineering approaches are presented. Clinical trials scenario for skin irritation testing is depicted along with the industry interactions.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Note: Product cover images may vary from those shown
2 of 2
Technological Innovation Profiles:
  • Labskin Mimics Skin Characteristics Enabling Real Usage Testing of Cosmetic Products
  • Skin Patch Test can be Used to Determine Skin Sensitization To Consumer Skin Products
  • Tissue Engineering In Vitro Reconstructed Epidermal Models for Product Irritation Testing
  • In Vitro Testing Products such as epiCS will Enable Better Skin Corrosion and Irritation Testing
  • Skin Irritation Testing Clinical Trials
  • Industry Contacts
Note: Product cover images may vary from those shown
3 of 2